Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orhan Sezer

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
Haematologica|May 10, 2007
Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018)Sven Trelle, Orhan Sezer, Ralph Naumann, et al.
European Journal of Haematology|January 15, 2013
The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signallingMartin F Kaiser, Ulrike Heider, Maren Mieth, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 24, 2010
Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7Gregor Kalwitz, Katja Neumann, Jochen Ringe, et al.
Journal of Microbiological Methods|January 28, 2004
Identification of clinically relevant yeasts by PCR/RFLPAnja Trost, Barbara Graf, Jan Eucker, et al.
Experimental Cell Research|May 5, 2009
Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myelomaIvana von Metzler, Ulrike Heider, Maren Mieth, et al.
Cell and Tissue Research|March 20, 2009
Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12Stefan Stich, Marion Haag, Thomas Häupl, et al.
Blood|June 18, 2002
Immunocytochemistry reveals RANKL expression of myeloma cellsOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
European Journal of Haematology|July 21, 2009
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patientsMartina Kleber, Gabriele Ihorst, Barbara Deschler, et al.
Experimental Cell Research|January 27, 2009
Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25Tabea Binger, Stefan Stich, Kristin Andreas, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
Haematologica|May 10, 2007
Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018)Sven Trelle, Orhan Sezer, Ralph Naumann, et al.
European Journal of Haematology|January 15, 2013
The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signallingMartin F Kaiser, Ulrike Heider, Maren Mieth, et al.
Journal of Tissue Engineering and Regenerative Medicine|July 24, 2010
Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7Gregor Kalwitz, Katja Neumann, Jochen Ringe, et al.
Journal of Microbiological Methods|January 28, 2004
Identification of clinically relevant yeasts by PCR/RFLPAnja Trost, Barbara Graf, Jan Eucker, et al.
Experimental Cell Research|May 5, 2009
Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myelomaIvana von Metzler, Ulrike Heider, Maren Mieth, et al.
Cell and Tissue Research|March 20, 2009
Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12Stefan Stich, Marion Haag, Thomas Häupl, et al.
Blood|June 18, 2002
Immunocytochemistry reveals RANKL expression of myeloma cellsOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
European Journal of Haematology|July 21, 2009
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patientsMartina Kleber, Gabriele Ihorst, Barbara Deschler, et al.
Experimental Cell Research|January 27, 2009
Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25Tabea Binger, Stefan Stich, Kristin Andreas, et al.
Pageof 11